| Issuer | % of Class | Filed | ||||
|---|---|---|---|---|---|---|
| Schedule 13D · 1 security · may seek to influence control | ||||||
|
Matinas BioPharma Holdings, Inc.
13D/A
MTNB · 576810303
|
10.0% |
8/13/2026
Event 6/10/2026
|
||||
| Sanitam Partners LLC | 0% | |||||
| Stern Adam K | 10.0% | |||||
Includes filings since 12/18/2024, when the SEC began requiring structured 13D and 13G data.